Correlation of SMN2, NAIP, p44, H4F5 and Occludin genes copy number with spinal muscular atrophy phenotype in Tunisian patients

被引:32
作者
Amara, Abdelbasset [1 ]
Adala, Labiba [1 ]
Ben Charfeddine, Ilhem [1 ]
Mamai, Ons [1 ]
Mili, Amira [1 ]
Ben Lazreg, Taheni [1 ]
H'mida, Dorra [1 ]
Amri, Fathi [2 ]
Salem, Najla [3 ]
Boughammura, Lamia [4 ]
Saad, Ali [1 ]
Gribaa, Moez [1 ]
机构
[1] Farhat Hached Univ Hosp, Lab Human Cytogenet Mol Genet & Reprod Biol, Sousse 4000, Tunisia
[2] Ibn El Jazzar Hosp, Dept Pediat, Kairouan, Tunisia
[3] Farhat Hached Univ Hosp, Dept Neonatol, Sousse 4000, Tunisia
[4] Farhat Hached Univ Hosp, Dept Pediat, Sousse 4000, Tunisia
关键词
SMA severity; SMN1; SMN2; NAIP; P44; H4F5; Occludin; Copy number; MLPA; DELETION ANALYSIS; SURVIVAL; IDENTIFICATION; PROTEIN; APOPTOSIS; SEVERITY; CELLS;
D O I
10.1016/j.ejpn.2011.07.007
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disorder which is characterized by a high clinical variability with severe, intermediate, mild and adult forms. These forms are caused, in 95% of cases, by a homozygous deletion of exon 7 of SMN1 gene. Our purpose was the determination of a possible genotype phenotype correlation between the copy number of SMN2, NAIP, p44, H4F5 and occludin genes localized in the same SMN1 region (5q13) and the severity of the disease in SMA Tunisian patients. Patients and methods: Twenty six patients affected by SMA were enrolled in our study. MLPA and QMPSF were used to measure copy numbers of these genes. Results: We found that 31.3% of type I patients carried one copy of SMN2, while all patients of other forms had at least 2 copies. NAIP was absent in 87.5% of type I patients. Furthermore, all SMA type I patients had one copy of H4F5. No correlation was found for p44 and occludin genes. Conclusion: There is a close relationship between SMN2, NAIP and H4F5 gene copy number and SMA disease severity, which is compatible with the previous reports. (C) 2011 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:167 / 174
页数:8
相关论文
共 26 条
[1]  
al-Rajeh S, 1999, East Mediterr Health J, V5, P1225
[2]  
Burglen L, 1997, AM J HUM GENET, V60, P72
[3]   Structure and organization of the human survival motor neurone (SMN) gene [J].
Burglen, L ;
Lefebvre, S ;
Clermont, O ;
Burlet, P ;
Viollet, L ;
Cruaud, C ;
Munnich, A ;
Melki, J .
GENOMICS, 1996, 32 (03) :479-482
[4]   Genomic variation and gene conversion in spinal muscular atrophy: Implications for disease process and clinical phenotype [J].
Campbell, L ;
Potter, A ;
Ignatius, J ;
Dubowitz, V ;
Davies, K .
AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (01) :40-50
[5]   Deletion analysis in Turkish patients with spinal muscular atrophy [J].
Erdem, H ;
Pehlivan, S ;
Topaloglu, H ;
Özgüç, M .
BRAIN & DEVELOPMENT, 1999, 21 (02) :86-89
[6]   Quantitative analyses of SMN1 and SMN2 based on real-time LightCycler PCR:: Fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy [J].
Feldkötter, M ;
Schwarzer, V ;
Wirth, R ;
Wienker, TF ;
Wirth, B .
AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 70 (02) :358-368
[7]   The SMN complex [J].
Gubitz, AK ;
Feng, WQ ;
Dreyfuss, G .
EXPERIMENTAL CELL RESEARCH, 2004, 296 (01) :51-56
[8]  
LAITINEN J, 1994, BIOTECHNIQUES, V17, P316
[9]   IDENTIFICATION AND CHARACTERIZATION OF A SPINAL MUSCULAR ATROPHY-DETERMINING GENE [J].
LEFEBVRE, S ;
BURGLEN, L ;
REBOULLET, S ;
CLERMONT, O ;
BURLET, P ;
VIOLLET, L ;
BENICHOU, B ;
CRUAUD, C ;
MILLASSEAU, P ;
ZEVIANI, M ;
LEPASLIER, D ;
FREZAL, J ;
COHEN, D ;
WEISSENBACH, J ;
MUNNICH, A ;
MELKI, J .
CELL, 1995, 80 (01) :155-165
[10]   Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes [J].
Liston, P ;
Roy, N ;
Tamai, K ;
Lefebvre, C ;
Baird, S ;
ChertonHorvat, G ;
Farahani, R ;
McLean, M ;
Ikeda, JE ;
MacKenzie, A ;
Korneluk, RG .
NATURE, 1996, 379 (6563) :349-353